GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a truly shift in how we handle type 2 diabetes . These new drugs function to mimicking the body’s inherent GLP-1 process, which https://bookmarklethq.com/story21669807/glp-1-a-revolutionary-breakthrough-in-diabetes-treatment